138 related articles for article (PubMed ID: 27574742)
1. Evaluation of Specialty Drug Price Trends Using Data from Retrospective Pharmacy Sales Transactions.
Penington R; Stubbings JA
J Manag Care Spec Pharm; 2016 Sep; 22(9):1010-7. PubMed ID: 27574742
[TBL] [Abstract][Full Text] [Related]
2. Specialty Drug Price Trends in the Federal 340B Drug Discount Program.
Lee CH; Chang J; McCombs J
J Manag Care Spec Pharm; 2019 Feb; 25(2):178-187. PubMed ID: 30698090
[TBL] [Abstract][Full Text] [Related]
3. Association Between the Percentage of US Drug Sales Subject to Inflation Penalties and the Extent of Drug Price Increases.
Dickson S
JAMA Netw Open; 2020 Sep; 3(9):e2016388. PubMed ID: 32915237
[TBL] [Abstract][Full Text] [Related]
4. The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
Wilson L; Turkistani FA; Huang W; Tran DM; Lin TK
PLoS One; 2018; 13(5):e0197449. PubMed ID: 29799850
[TBL] [Abstract][Full Text] [Related]
5. Meeting the affordability challenges posed by orphan drugs: a survey of payers, providers, and employers.
Lopata E; Terrone C; Gopalan A; Ladikos N; Richardson T
J Manag Care Spec Pharm; 2021 Jun; 27(6):706-713. PubMed ID: 33586514
[No Abstract] [Full Text] [Related]
6. Financial impact of integrated specialty pharmacy efforts to avoid oral anticancer medication waste.
Looney B; Crumb J; White S; Jones G; Moore RP; Choi L; Zuckerman AD; Whelchel K
J Manag Care Spec Pharm; 2024 May; 30(5):465-474. PubMed ID: 38701029
[TBL] [Abstract][Full Text] [Related]
7. Health plan utilization and costs of specialty drugs within 4 chronic conditions.
Gleason PP; Alexander GC; Starner CI; Ritter ST; Van Houten HK; Gunderson BW; Shah ND
J Manag Care Pharm; 2013 Sep; 19(7):542-8. PubMed ID: 23964615
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
Kale HP; Patel AM; Carroll NV
J Manag Care Spec Pharm; 2018 Apr; 24(4):317-326. PubMed ID: 29578855
[TBL] [Abstract][Full Text] [Related]
9. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
[TBL] [Abstract][Full Text] [Related]
10. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
Bagwell A; Kelley T; Carver A; Lee JB; Newman B
J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
[TBL] [Abstract][Full Text] [Related]
11. National trends in prescription drug expenditures and projections for 2016.
Schumock GT; Li EC; Suda KJ; Wiest MD; Stubbings J; Matusiak LM; Hunkler RJ; Vermeulen LC
Am J Health Syst Pharm; 2016 Jul; 73(14):1058-75. PubMed ID: 27170624
[TBL] [Abstract][Full Text] [Related]
12. Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?
Mattingly TJ; Levy JF; Slejko JF; Onwudiwe NC; Perfetto EM
Pharmacoeconomics; 2018 Sep; 36(9):1093-1099. PubMed ID: 29752675
[TBL] [Abstract][Full Text] [Related]
13. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
14. Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program.
Keast SL; Pham T; Teel A; Nesser NJ
J Manag Care Spec Pharm; 2017 Aug; 23(8):875-883. PubMed ID: 28737989
[TBL] [Abstract][Full Text] [Related]
15. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
[TBL] [Abstract][Full Text] [Related]
16. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
Li DG; Joyce C; Mostaghimi A
JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
[TBL] [Abstract][Full Text] [Related]
17. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
Gross DJ; Schondelmeyer SW; Raetzman SO
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
[TBL] [Abstract][Full Text] [Related]
18. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
19. Number of manufacturers and generic drug pricing from 2005 to 2017.
Hernandez I; Good CB; Gellad WF; Parekh N; He M; Shrank WH
Am J Manag Care; 2019 Jul; 25(7):348-352. PubMed ID: 31318508
[TBL] [Abstract][Full Text] [Related]
20. Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system.
Brouwer E; Yeung K; Barthold D; Hansen R
J Manag Care Spec Pharm; 2021 Jun; 27(6):732-742. PubMed ID: 34057391
[No Abstract] [Full Text] [Related]
[Next] [New Search]
